Vitamin D status and the risk for hospital-acquired infections in critically ill adults: a prospective cohort study
- PMID: 25849649
- PMCID: PMC4388655
- DOI: 10.1371/journal.pone.0122136
Vitamin D status and the risk for hospital-acquired infections in critically ill adults: a prospective cohort study
Abstract
Introduction: To identify patient characteristics associated with low serum 25-hydroxyvitamin D (25(OH)D) concentrations in the medical intensive care unit (ICU) and examine the relationship between serum 25(OH)D and the risk for hospital-acquired infections.
Methods: This is a prospective observational cohort of adult patients admitted to the medical ICU at an urban safety net teaching hospital in Atlanta, Georgia from November 1, 2011 through October 31, 2012 with an anticipated ICU stay ≥ 1 day. Phlebotomy for serum 25(OH)D measurement was performed on all patients within 5 days of ICU admission. Patients were followed for 30 days or until death or hospital discharge, whichever came first. Hospital-acquired infections were determined using standardized criteria from review of electronic medical record.
Results: Among the 314 patients analyzed, 178 (57%) had a low vitamin D at a serum 25(OH)D concentration < 15 ng/mL. The patient characteristics associated with low vitamin D included admission during winter months (28% vs. 18%, P = 0.04), higher PaO2/FiO2 (275 vs. 226 torr, P = 0.03) and a longer time from ICU admission to study phlebotomy (1.8 vs. 1.5 days, P = 0.02). A total of 36 (11%) patients were adjudicated as having a hospital-acquired infection and in multivariable analysis adjusting for gender, alcohol use, APACHE II score, time to study phlebotomy, ICU length of stay and net fluid balance, serum 25(OH)D levels < 15 ng/mL were not associated with risk for hospital-acquired infections (HR 0.85, 95% CI 0.40-1.80, P = 0.7).
Conclusions: In this prospective, observational cohort of adults admitted to a single-center medical ICU, we did not find a significant association between low 25(OH)D and the risk for hospital-acquired infections.
Conflict of interest statement
Figures





References
Publication types
MeSH terms
Substances
Grants and funding
- K01 DK102851/DK/NIDDK NIH HHS/United States
- K23 AR054334/AR/NIAMS NIH HHS/United States
- T32 AA13528/AA/NIAAA NIH HHS/United States
- T32 DK007298/DK/NIDDK NIH HHS/United States
- L30 HL124529/HL/NHLBI NIH HHS/United States
- R01 FD003440/FD/FDA HHS/United States
- R21 HL110044/HL/NHLBI NIH HHS/United States
- UL1 TR000454/TR/NCATS NIH HHS/United States
- K23 AI103044/AI/NIAID NIH HHS/United States
- T32 DK007298-32S1/DK/NIDDK NIH HHS/United States
- T32 AA013528/AA/NIAAA NIH HHS/United States
- R01 FD-003440/FD/FDA HHS/United States
- K24 DK096574/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical